SUPPLIERS
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15055
Submission : 2000-09-20
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15460
Submission : 2001-05-31
Status : Active
Type : IV
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15460
Submission : 2001-05-31
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15055
Submission : 2000-09-20
Status : Active
Type : IV
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
Drug : K-TAB
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 18279
Country : US
Patented : No
Drug : OLANZAPINE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 204320
Country : US
Patented : No
Drug : VENLAFAXINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 209193
Country : US
Patented : No
Drug : QUILLICHEW ER
Dosage Form : TABLET, EXTENDED RELEASE, CHEWABLE; ORAL
Application Number : 207960
Country : US
Patented : Yes
Drug : DEXTROMETHORPHAN POLISTIREX
Dosage Form : SUSPENSION, EXTENDED RELEASE; ORAL
Application Number : 91135
Country : US
Patented : No
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
Drug : DYANAVEL XR 20
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210526
Country : US
Patented : Yes
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
Drug : DYANAVEL XR 15
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210526
Country : US
Patented : Yes
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
Drug : DYANAVEL XR 10
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210526
Country : US
Patented : Yes
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
Drug : DYANAVEL XR 5
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210526
Country : US
Patented : Yes
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
Drug : DYANAVEL XR
Dosage Form : SUSPENSION, EXTENDED RELEASE; ORAL
Application Number : 208147
Country : US
Patented : Yes
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Listed Dossiers
POLYVINYL ACETATE
Route : ORAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 6.41
Potency Unit : MG/1ML
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYVINYL ACETATE
Route : ORAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 92.9
Potency Unit : MG/5ML
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYVINYL ACETATE
Route : ORAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 19.24
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYVINYL ACETATE
Route : ORAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 25.82
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYVINYL ACETATE
Route : ORAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 46
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYVINYL ACETATE
Route : SUBLINGUAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 8.07
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYVINYL ACETATE
Route : TRANSDERMAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 16
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYVINYL ACETATE
Route : TRANSDERMAL
CAS : 9003-20-7
UNII : 32K497ZK2U
Potency Amount : 3.99
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Controlled Modified Release
Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film
Grade : Not Available
Category : Controlled & Modified Release
Brand Name : Kollicoat SR 30 D
Application : Controlled & Modified Release
Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.
Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch
Grade : Not Available
Category : Controlled & Modified Release
Application : Controlled & Modified Release
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Dosage Form : Tablet, Topical Film, Transdermal Patch
Grade : Not Available
Category : Controlled & Modified Release
Application : Controlled & Modified Release
Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)
Pharmacopoeia Ref : Polyvinyl caprolactam – poly...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Granulation
Application : Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Application : Granulation
Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)
Pharmacopoeia Ref : Polyvinyl caprolactam – poly...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Application : Granulation
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Direct Compression
Application : Direct Compression
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Application : Direct Compression
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Solubilizers
Taste Masking
Chewable Orodispersible Aids
Application : Chewable & Orodispersible Aids
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Acetate
Coating Systems Additives
MARKET PLACE
EXCIPIENTS
Reply
09 Oct 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
Others
CAS Number : 9003-20-7
Quantity Per Vial : 1
Sale Unit : g
Price : $312.00
Details : Material Origin- Unavailable; USMCA- No; KORU...
Monograph :
Storage :
Code/Batch No : Catalog #1548032 / F0H014
Polyvinyl Acetate Dispersion (1 g) (Polyvinyl...
CAS Number : 9003-20-7
Quantity Per Vial : 1
Sale Unit : g
Price : $278.00
Details : Material Origin- Plant - Synthetic; USMCA- No...
Monograph :
Storage :
Code/Batch No : Catalog #1548043 / R050P0
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Comment (5)
